Potent Efficacy of BCL2 Inhibition with ABT-199 in High-Risk Aggressive B-Lymphoma Models When Combined with Knockdown of MCL1
Year: 2014
Type: article
Source: Blood
Institutions: University of Arizona Cancer Center, University of Arizona
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W194958640
